Ana Kostic

In the United States, there are 11 individuals named Ana Kostic spread across 7 states, with the largest populations residing in Illinois, Florida, Maine.

Public information about Ana Kostic

Resumes

Senior Associate

Location:

Chicago, IL

Work:

Bdo Usa, Llp
Senior Associate

Medical Doctor

Work:

Den
Medical Doctor

Director, Drug Discovery And Development

Location:

New York, NY

Industry:

Biotechnology

Work:

Seaver Autism Center Mount Sinai
Director, Drug Discovery and Development Kiniksa Pharmaceuticals Jan 2018 - Oct 2018
Senior Director Regeneron Pharmaceuticals, Inc. Jan 2017 - Jan 2018
Director Regeneron Pharmaceuticals, Inc. Jan 2015 - Jan 2017
Associate Director Regeneron Pharmaceuticals, Inc. Mar 2012 - Dec 2014
Senior Manager, Predictive Medicine Regeneron Pharmaceuticals, Inc. Jan 2011 - Mar 2012
Staff Scientist Regeneron Pharmaceuticals, Inc. Jan 2009 - Dec 2010
Scientist Regeneron Pharmaceuticals, Inc. Feb 2008 - Dec 2008
Postdoctoral Research Scientist Columbia University In the City of New York May 2007 - Jan 2008
Postdoctoral Fellow

Education:

Columbia University In the City of New York 2001 - 2007
Doctorates, Doctor of Philosophy Columbia University In the City of New York 2001 - 2003
Masters, Master of Arts, Philosophy University of Belgrade 1995 - 2000
Bachelors, Bachelor of Science, Molecular Biology, Physiology

Skills:

Molecular Biology, Biotechnology, Drug Discovery, Immunology, Life Sciences, Biochemistry, Drug Development, Cell Culture, Cell Biology, Cell, Lifesciences, Assay Development, Biopharmaceuticals, Protein Chemistry, Clinical Development, Protein Purification, Elisa, Technology Transfer, Oncology, Neuroscience, Biomarker Discovery, Cancer Biology, Ankylosing Spondylitis

Ana Kostic

Professional

Location:

United States

Experienced Associate

Location:

Chicago, IL

Industry:

Information Technology And Services

Work:

Bdo Usa, Llp
Experienced Associate Nextgen Technology Limited
Iop Test Engineer Federal Reserve Bank of Chicago Dec 2012 - Jan 2013
Nac Analyst Sentinel Technologies Jul 2012 - Sep 2012
Intern Federal Reserve Bank May 2012 - Jun 2012
Nac Intern Robert Morris University, Chicago, Il Jun 2011 - Apr 2012
Student Ambassador

Education:

Robert Morris University - Illinois 2010 - 2012
Bachelor of Applied Science, Bachelors

Skills:

Troubleshooting, Networking, Microsoft Office, Cisco Ios, Cisco Technologies, Network Administration, Windows, Computer Hardware, Windows 7, Windows Server, Active Directory, Java, Html, Computer Repair, Microsoft Sql Server

Ana Kostic

Location:

Seattle, WA

Industry:

Management Consulting

Education:

University of Belgrade 2001 - 2008

Skills:

Genetics, Medical Affairs

Ana Kostic

Background search with BeenVerified

Background Search for Ana Kostic

Phone Address Email Family Social Criminal Property Bankruptcy Residence

Data provided by Veripages

Phones & Addresses

Name

Addresses

Phones

Ana Anka Kostic

4433 Prescott Ave #A, Lyons, IL 60534

Ana Anka Kostic

600 N Mcclurg Ct, Chicago, IL 60611

312-477-5003

Ana P Kostic

225 S Sangamon St UNIT 707, Chicago, IL 60607

630-993-9196

Ana Kostic

2612 Sam Calvin Dr, Dacula, GA 30019

404-545-4846

Ana Kostic

7033 N Kedzie Ave #1205, Chicago, IL 60645

Ana Kostic

4300 16Th St, Chicago, IL 60623

773-521-0264

Ana Kostic

528 Riverside Dr, New York, NY 10027

646-698-5055

Ana Anka Kostic

14226, Chicago, IL 60614

Publications

Us Patents

Anti-Cd48 Antibodies And Uses Thereof

US Patent:

2012007, Mar 29, 2012

Filed:

Sep 26, 2011

Appl. No.:

13/244960

Inventors:

Brendan J. CLASSON - Ridgefield CT, US
Ana Kostic - New York NY, US
Xunbao Duan - Horsham PA, US

Assignee:

Regeneron Pharmaceuticals, Inc. - Tarrytown NY

International Classification:

A61K 39/395
A61P 1/00
A61P 17/06
C07K 16/18

US Classification:

4241391, 5303879

Abstract:

The present invention provides antibodies that bind to CD48 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human CD48. In certain embodiments, the antibodies of the present invention block the binding of CD48 to one or more CD48 receptor. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more CD48 biological activities, including the treatment of allergic conditions and other inflammatory conditions.

Anti-Hla-B*27 Antibodies And Uses Thereof

US Patent:

2013025, Oct 3, 2013

Filed:

Apr 2, 2013

Appl. No.:

13/855448

Inventors:

Ana Kostic - New York NY, US

Assignee:

Regeneron Pharmaceuticals, Inc. - Tarrytown NY

International Classification:

C07K 16/28

US Classification:

4241731, 5303896

Abstract:

The present invention provides antibodies and antigen-binding fragments thereof that specifically bind HLA-B*27 (also called HLA-B27). In certain embodiments, the antibodies of the invention bind soluble and/or cell surface-expressed forms of HLA-B*27. The antibodies of the present invention, in certain embodiments, inhibit HLA-B*27-mediated activation of T cells. Certain exemplary antibodies of the present invention exhibit enhanced binding to HLA-B*27 as compared to other HLA-B allelic variants (e.g., HLA-B*07). The present invention also provides anti-HLA-B*27 antibodies with pH-dependent binding characteristics (e.g., higher affinity binding at neutral pH than at acidic pH). The antibodies of the invention are useful for the treatment of diseases and disorders associated with HLA-B*27 expression, including ankylosing spondylitis and other spondyloarthropathies.

Combination Therapy Using A Liv1-Adc And A Chemotherapeutic

US Patent:

2019008, Mar 21, 2019

Filed:

Mar 15, 2017

Appl. No.:

16/085511

Inventors:

- Bothell WA, US
Fu Li - Bothell WA, US
Ana Kostic - Seattle WA, US

Assignee:

SEATTLE GENETICS, INC. - Bothell WA

International Classification:

C07K 16/30
A61K 9/00
A61K 31/337
A61K 31/555
A61K 31/704

Abstract:

The invention provides methods of treating a subject having or at risk of cancer by administering a LIV-1 antibody drug conjugate and a chemotherapeutic.

Methods Of Treating Systemic Lupus Erythematosus (Sle) Using Anti-Cd48 Antibodies

US Patent:

2013023, Sep 5, 2013

Filed:

Apr 18, 2013

Appl. No.:

13/865232

Inventors:

ANA KOSTIC - NEW YORK NY, US
XUNBAO DUAN - HORSHAM PA, US

Assignee:

REGENERON PHARMACEUTICALS, INC. - Tarrytown NY

International Classification:

A61K 39/395

US Classification:

4241391

Abstract:

Combination Therapy Using A Cd19-Adc And Rchp

US Patent:

2020023, Jul 23, 2020

Filed:

Jul 21, 2017

Appl. No.:

16/319147

Inventors:

- Bothell WA, US
Ana Kostic - Seattle WA, US

Assignee:

SEATTLE GENETICS, INC. - Bothell WA

International Classification:

A61K 47/68
A61K 39/395
A61P 35/00
A61K 31/573
A61K 31/675
A61K 31/475
A61K 31/704

Abstract:

This invention relates to treatment of Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL). Specifically, the disclosure provides a method of treating a subject having DLBCL or FL, the method comprising administering to the subject a drug combination consisting essentially of a CD19 antibody drug conjugate (CD19-ADC), and rituximab, cyclophosphamide, doxorubicin, and prednisone (RCHP).

Method Of Treating An Allergy With Allergen-Specific Monoclonal Antibodies

US Patent:

2020025, Aug 13, 2020

Filed:

Dec 15, 2017

Appl. No.:

16/471213

Inventors:

- Tarrytown NY, US
Namita GRANDHI - New York NY, US
Allen RADIN - New York NY, US
Ana KOSTIC - New York NY, US
Andrew J. MURPHY - Croton-on-Hudson NY, US
George D. YANCOPOULOS - Yorktown Heights NY, US

International Classification:

C07K 16/18

Abstract:

The present invention provides methods for treating an allergy by administering one or more antibodies that bind specifically to the allergen. In certain embodiments, the antibodies useful for treating an allergen, bind specifically to the cat allergen, Fel d1. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to Fel d1. The antibodies of the invention are useful for binding to the Fel d1 allergen in vivo, thus preventing binding of the Fel d1 allergen to pre-formed IgE on the surface of mast cells or basophils. In doing so, the antibodies act to prevent the release of histamine and other inflammatory mediators from mast cells and/or basophils, thus ameliorating the untoward response to the cat allergen in sensitized individuals.

Humanized Anti-Liv1 Antibodies For The Treatment Of Breast Cancer

US Patent:

2020028, Sep 10, 2020

Filed:

Nov 30, 2018

Appl. No.:

16/768020

Inventors:

- Bothell WA, US
Ana KOSTIC - Seattle WA, US
Elizabeth CORWIN - Seattle WA, US
Jonathan DRACHMAN - Seattle WA, US
Peter HAUGHNEY - Seattle WA, US
Baiteng ZHAO - Woodinville WA, US
Phillip GARFIN - Bothell WA, US
Oyewale O. ABIDOYE - Bellevue WA, US

International Classification:

C07K 16/30
A61K 38/19
A61K 39/395
A61K 47/68

Abstract:

Methods for using anti-LIV1 antibodies, including dmg conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.

Videos & Images

FAQ: Learn more about Ana Kostic

Where does Ana Kostic live?

Downers Grove, IL is the place where Ana Kostic currently lives.

How old is Ana Kostic?

Ana Kostic is 50 years old.

What is Ana Kostic date of birth?

Ana Kostic was born on 1974.

What is Ana Kostic's telephone number?

Ana Kostic's known telephone numbers are: 630-993-9196, 773-521-0264, 312-240-1120, 312-477-5003, 404-545-4846, 646-698-5055. However, these numbers are subject to change and privacy restrictions.

How is Ana Kostic also known?

Ana Kostic is also known as: Ana Mladenovic Kostic, Ana Solunac, Ana Mladenovic, Ana C. These names can be aliases, nicknames, or other names they have used.

Who is Ana Kostic related to?

Known relative of Ana Kostic is: Kenneth Willis. This information is based on available public records.

What are Ana Kostic's alternative names?

Known alternative name for Ana Kostic is: Kenneth Willis. This can be alias, maiden name, or nickname.

What is Ana Kostic's current residential address?

Ana Kostic's current known residential address is: 7306 Winthrop Way Unit 1, Downers Grove, IL 60516. Please note this is subject to privacy laws and may not be current.

What are the previous addresses of Ana Kostic?

Previous addresses associated with Ana Kostic include: 225 S Sangamon St Unit 707, Chicago, IL 60607; 7306 Winthrop Way Unit 1, Downers Grove, IL 60516; 4300 W 16Th St, Chicago, IL 60623; 195 Harbor Dr, Chicago, IL 60601; 1050 64Th St #6, La Grange, IL 60525. Remember that this information might not be complete or up-to-date.

Where does Ana Kostic live?

Downers Grove, IL is the place where Ana Kostic currently lives.

Name Variants	Anastasia Kostic	Anita Kostic
Ages	33 to 67
Phones	630-993-9196	773-521-0264	312-240-1120
Addresses	372 5Th Ave Apt 8F, New York, NY 10018	225 S Sangamon St Unit 707, Chicago, IL 60607	7306 Winthrop Way Unit 1, Downers Grove, IL 60516
Business records	Director, Drug Discovery and Development / Seaver Autism Center Mount Sinai	Experienced Associate / Bdo Usa, Llp	Senior Associate / Bdo Usa, Llp

Ana Kostic

What do we know about Ana Kostic

Public information about Ana Kostic

Resumes

Resumes

Senior Associate

Medical Doctor

Director, Drug Discovery And Development

Ana Kostic

Professional

Experienced Associate

Ana Kostic

Ana Kostic

Phones & Addresses

Publications

Us Patents

Anti-Cd48 Antibodies And Uses Thereof

Anti-Hla-B*27 Antibodies And Uses Thereof

Combination Therapy Using A Liv1-Adc And A Chemotherapeutic

Methods Of Treating Systemic Lupus Erythematosus (Sle) Using Anti-Cd48 Antibodies

Combination Therapy Using A Cd19-Adc And Rchp

Method Of Treating An Allergy With Allergen-Specific Monoclonal Antibodies

Humanized Anti-Liv1 Antibodies For The Treatment Of Breast Cancer

FAQ: Learn more about Ana Kostic

Possible Relatives